Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Generac Holdings Inc. Stock Advances 3.4%, Outperforms Peers

Generac Holdings Inc. Stock Advances 3.4%, Outperforms Peers

Dow JonesDow Jones2026/09/29 20:34

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Generac Holdings Inc. advanced 3.4% to $212.22 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.2% to 7,670.84 and Dow Jones Industrial Average falling 0.3% to 51,349.92.

Generac Holdings Inc. closed 28.4% below its 52-week high of $296.44, which the company reached on June 25th.

The stock outperformed some of its peers, as Honeywell International Inc. fell 0.7% to $210.13, Amphenol Corp. Cl A fell 0.3% to $84.34, and Enphase Energy Inc. rose 2.98% to $31.83.

Trading volume totaled 1.3 million, compared to the 50-day average of 1.3 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 29, 2026 16:34 ET (20:34 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks